Publicaciones en colaboración con investigadores/as de Instituto Universitario de Oncologia del Principado de Asturias (22)

2022

  1. Acetoxymethyl-BODIPY dyes: a universal platform for the fluorescent labeling of nucleophiles

    Organic Chemistry Frontiers, Vol. 9, Núm. 21, pp. 5774-5789

  2. Differential HIF2α Protein Expression in Human Carotid Body and Adrenal Medulla under Physiologic and Tumorigenic Conditions

    Cancers, Vol. 14, Núm. 12

2021

  1. Three-dimensional bioprinted cancer models: A powerful platform for investigating tunneling nanotube-like cell structures in complex microenvironments

    Materials Science and Engineering C, Vol. 128

2020

  1. Blockage of squamous cancer cell collective invasion by FAK inhibition is released by CAFs and MMP-2

    Cancers, Vol. 12, Núm. 12, pp. 1-24

  2. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis

    International Journal of Cancer, Vol. 146, Núm. 2, pp. 373-387

  3. Shedding light on the mitochondrial matrix through a functional membrane transporter

    Chemical Science, Vol. 11, Núm. 4, pp. 1052-1065

  4. The IGF2 methylation score for adrenocortical cancer: An ENSAT validation study

    Endocrine-Related Cancer, Vol. 27, Núm. 10, pp. 541-550

  5. The Leader Position of Mesenchymal Cells Expressing N-Cadherin in the Collective Migration of Epithelial Cancer

    Cells, Vol. 9, Núm. 3

2019

  1. A general modular approach for the solubility tagging of BODIPY dyes

    Dyes and Pigments, Vol. 170

  2. Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment

    Nucleic Acids Research, Vol. 47, Núm. 10, pp. 5016-5037

  3. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas

    Head and Neck, Vol. 41, Núm. 1, pp. 79-91

2018

  1. Epigenetic dysregulation of TET2 in human glioblastoma

    Oncotarget, Vol. 9, Núm. 40, pp. 25922-25934

2012

  1. Identification of a signaling Axis HIF-1α/MicroRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 11

  2. MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma

    Clinical Cancer Research, Vol. 18, Núm. 10, pp. 2828-2837

2009

  1. Increase in gene dosage is a mechanism of HIF-lα constitutive expression in head and neck squamous cell carcinomas

    Genes Chromosomes and Cancer, Vol. 48, Núm. 5, pp. 441-454

  2. Significado pronóstico de la angiogénesis en los carcinomas epidermoides de laringe supraglótica tratados con cirugía

    Acta Otorrinolaringologica Espanola, Vol. 60, Núm. 4, pp. 272-277

  3. The relation between Hypoxia-Inducible Factor (HIF)-1alpha expression with p53 expression and outcome in surgically treated supraglottic laryngeal cancer

    Journal of Surgical Oncology, Vol. 99, Núm. 6, pp. 373-378

2008

  1. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression

    British Journal of Cancer, Vol. 98, Núm. 7, pp. 1274-1284

2007

  1. Focal adhesion kinase and E-cadherin as markers for nodal metastasis in laryngeal cancer

    Archives of Otolaryngology - Head and Neck Surgery, Vol. 133, Núm. 2, pp. 145-150

  2. P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph mode metastases: New results for an old question

    Cancer, Vol. 109, Núm. 9, pp. 1791-1798